| Author(s) | Boujendar S; Reusens B; Merezak S; Ahn MT; Arany E; Hill D; Remacle C
|
|---|
| Title | Thurine supplementation to a low protein diet during foetal and early postnatal life restores a normal proliferation and apoptosis of rat pancreatic islets
|
|---|
| Source | DIABETOLOGIA 45 (6): 856-866
|
|---|
| Date | 2002 JUN
|
|---|
| Type | Journal : Article
|
|---|
| LCR: 1 NCR: 44 LCS: 0 GCS: 15
| | Comment |
|
|---|
| Address | Catholic Univ Louvain, Cell Biol Lab, World Hlth Collaborating Ctr Dev Endocrine Pancre, B-1348 Louvain, Belgium.
St Josephs Hlth Care, Lawson Hlth Res Inst, London, ON, Canada.
Univ Western Ontario, Dept Med, London, ON N6A 3K7, Canada.
Univ Western Ontario, Dept Physiol, London, ON N6A 3K7, Canada.
Univ Western Ontario, Dept Paediat, London, ON N6A 3K7, Canada.
|
|---|
| Reprint | Remacle, C, Catholic Univ Louvain, Cell Biol Lab, World Hlth
Collaborating Ctr Dev Endocrine Pancre, B-1348 Louvain, Belgium.
|
|---|
| Abstract | Aims/hypothesis. In our previous studies a low protein diet (8% vs 20%) given during foetal and early postnatal life induced abnormal development of the endocrine pancreas; beta-cell mass and islet-cell proliferation were reduced while apoptosis was increased. Taurine, an important amino acid for development was also reduced in maternal and foetal plasma of protein deficient animals. In this study we aim to evaluate the role of taurine in the alterations observed in rats after a low protein diet. Methods. Four groups of rats were given either a control, a low protein, or control and low protein diets with 2.5% taurine in the drinking, water. Diets were given to gestating and lactating mothers and to their pups until day 30. Beta and endocrine cell masses were analysed as well as DNA synthesis and apoptosis after taurine supplementation in foetuses and pups. We also investigated insulin like growth factor-II (IGF-II), inducible nitric oxide synthase (iNOS), and Fas by immunohistochemistry. Results. In foetuses and neonates nourished with a low protein diet, taurine supplementation restored normal DNA synthesis and apoptosis. This led to adequate beta and endocrine cell mass in pups. In islet cells, immunoreactivity was increased for IGF-II, reduced for Fas and unchanged for iNOS after taurine supplementation. Conclusion/interpretation. Taurine supplementation to a low protein diet in foetal and early postnatal life prevents the abnormal development of the endocrine pancreas. The mechanisms by which taurine acts on DNA synthesis and apoptosis rate of endocrine cells involve IGF-II, Fas regulation but not iNOS.
|
|---|
| CR |
BUSTAMANTE J, 1998, ADV EXP MED BIOL, V442, P65
CAMPANA D, 1988, J IMMUNOL METHODS, V107, P79
CHERIF H, 1996, J ENDOCRINOL, V151, P501
CHERIF H, 1998, J ENDOCRINOL, V159, P341
DAHRI S, 1991, DIABETES S2, V40, P115
GABRIELIAN K, 1992, CURR EYE RES, V11, P481
GAROFANO A, 1997, DIABETOLOGIA, V40, P1231
GAULL GE, 1983, SULFUR AMINO ACIDS B, P297
HALES CN, 1992, DIABETOLOGIA, V35, P595
HANKE J, 2000, ANAT EMBRYOL, V202, P303
HARRRISON M, 1998, FEBS LETT, V435, P207
HELLERSTROM C, 1985, DIABETIC PANCREAS, P53
HILL DJ, 1999, J ENDOCRINOL, V161, P153
HOGG J, 1994, DIABETES, V36, P465
HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101
KAUNG HLC, 1994, DEV DYNAM, V200, P163
KULAKOWSKI EC, 1984, BIOCHEM PHARMACOL, V33, P2835
LAMPSON WG, 1983, CAN J PHYSIOL PHARM, V61, P457
LANG F, 1998, PFLUG ARCH EUR J PHY, V436, P377
LANG F, 2000, PFLUG ARCH EUR J PHY, V440, P93
LIM E, 1998, TAURINE, V3, P99
LOWETH AC, 1998, DIABETES, V47, P727
MALANDRO MS, 1996, AM J PHYSIOL-CELL PH, V271, PC295
MARIA RD, 1998, IMMUNOL TODAY, V19, P121
MEREZAK S, 2001, J ENDOCRINOL, V171, P299
MOURMEAUX JL, 1985, MOL CELL ENDOCRINOL, V39, P237
NORBERG S, 1998, PEDIATR RES, V44, P233
PETRIK J, 1998, ENDOCRINOLOGY, V139, P2994
PETRIK J, 1999, ENDOCRINOLOGY, V140, P4861
RABINOVITCH A, 1982, DIABETES, V31, P160
REDMOND HP, 1996, ARCH SURG-CHICAGO, V131, P1280
REMACLE C, 2000, DIABETES RES CLIN S, V1, PP615
REUSENS B, 1995, NESTLE NUTR WORKS SE, V35, P187
REUSENS B, 2000, FETAL ORIGINS CARDIO, V17, P339
SCAGLIA L, 1997, ENDOCRINOLOGY, V138, P1736
SCUTTE B, 1987, J HISTOCHEM CYTOCHEM, V35, P1343
SGONC R, 1994, TRENDS GENET, V10, P41
SNOECK A, 1990, BIOL NEONATE, V57, P107
STURMAN JA, 1993, PHYSIOL REV, V73, P119
WANG JH, 1996, SHOCK, V6, P331
WU QD, 1999, AM J PHYSIOL, V277, PC1229
ZELIKOVIC I, 1990, J PEDIATR, V116, P301
ZHANG XJ, 1999, BIOCHEM PHARMACOL, V57, P1331
ZUMSTEG U, 2000, DIABETES, V49, P39
|
|---|
|